(
148
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Baseline demographics and disease characteristics of patients with eosinophilic esophagitis in part A of the 3-part, randomized, placebo-controlled, phase 3 TREET study
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
EAACI & WAO joint symposium: World Allergy Forum, Mast cells – biology and disease
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Pathogenic Th cell population disease induction model: – From the recruitment of eosinophils to the induction of fibrosis
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
ÖGAI: Covid as best practice model to combine immunology and allergy
Show more Event Resources (5)Show Less-
-
Biologicals in atopic disease in pregnancy: An EAACI position paper
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
Show more Position Papers (3)Show Less-
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Pioneering a new age – fighting allergic disease on all fronts!
-
Supporting individual patients’ needs: AIT still an unmatched model of personalized medicine for allergy
Show more Sponsored Symposia (2)Show Less-
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention
-
Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy
-
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures
Show more Covid-19 (1)Show Less-
Website
Collapse
-
A Brown Norway rat model based on intraperitoneal injections can distinguish between low-, medium-, and high-allergenic foods
-
A dual-reporter mouse model (IFN-γ/IL-4) for simultaneous in vivo screening of Th1/Th2 populations initiated by allergenic pollen extracts
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A stepwise approach to the management of a patient with celiac disease and multiple IgE-mediated food allergies
-
Acquired angioedema: addressing the underlying disease
-
An adjuvant-free in vivo model for the differential analysis of early Th2 versus IgE responses induced by inhalation of house dust mites
-
Analysis of allergenic activity of recombinant Der p 23 in a mouse model of airway inflammation
-
Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
-
Basal serum tryptase levels identify hereditary α-tryptasemia but are poor predictors of clonal mast cell disease in Hymenoptera venom allergy
-
Baseline Demographics and Disease Characteristics of Pediatric Patients with Eosinophilic Esophagitis (EoE) from the Randomized, Placebo-Controlled, Phase 3 EoE KIDS Study
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Baseline IgE Levels Predict an Unstable Disease Course in Adults With Severe Atopic Dermatitis That is Stabilized by Dupilumab Therapy
-
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Beta-lactam allergy de-labeling – usefulness of a model based on a medical history data
-
Blomia Tropicalis (a house dust mite) is the most important sensitization in patients with Allergic Airways Disease in Reunion Island (Tropical region)
-
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Cockroach Allergen-Induced Asthma Model Elicited in Mice Expressing Chimeric Human/Mouse CD117
-
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Epicutaneous Allergen-Induced Atopic Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117
-
Burden of Disease and Health-Related Quality of Life Impairment in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
-
Can we achieve remission or disease modification in CRSwNP?
-
Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis
-
Case report of an occupational disease in a veterinarian with allergic asthma
-
Clinical experience with targeting TSLP: reducing patient burden of disease
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
Coexistence of Celiac Disease and Wheat Allergy – more than a coincidence?
-
Comorbidity in airways disease and its impact
-
Comparing intrinsic sensitizing capacity of cow’s milk allergens β-lactoglobulin and αs-casein with hen’s egg allergen ovalbumin in an in vitro co-culture model using human epithelial and dendritic cells
-
Comparison of the efficacy of omalizumab and mepolizumab in non-steroidal anti-inflammatory drug-exacerbated respiratory disease
-
Dermatomyositis, a dangerous disease hiding in the skin: a case series of atypical presentation
-
Development and evaluation of an artificial intelligence model to support read out of skin prick automated test results: a multicentre study
-
Development of a preclinical murine model for peanut protein allergy
-
Development of an in vitro immunocompatible intestine-on-a-chip model to study allergic sensitization
-
Development of an in vitro immunocompatible intestine-on-a-chip model to study allergic sensitization
-
Disease burden and medication use in children with symptomatic, perennial allergic rhinitis in Canada, Denmark, and the UK: a cross-sectional survey
-
Disease burden in ISM: Using PRO tools to assess the individual patient experience
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Dupilumab Improves Urticaria Activity, Health-Related Quality of Life, and Disease Perception and Severity in Patients with CSU: Results From the LIBERTY-CSU CUPID A Study
-
Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children
-
EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease
-
EAACI & NIAID Joint Symposium : Harnessing the Potential of Endotyping Data to Predict Clinical Outcomes in Allergic Disease
-
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
-
Effect of Remibrutinib on Disease Activity in Patients with Chronic Spontaneous Urticaria: Post Hoc Analysis of Phase 3 REMIX-1 and REMIX-2 studies
-
Effects of dupilumab on quality of life and airflow obstruction in refractory type 2 high severe unified airways disease
-
Efficacy of Dupilumab by Baseline Disease Severity in Children Aged 6 to 11 Years With Uncontrolled Moderate-to-Severe Asthma: Post Hoc Results From the Randomized, Placebo-Controlled VOYAGE Trial
-
Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy
-
Endotypes united airways disease
-
Endotyping in Eosinophilic GI disease
-
Evaluation of Disease Activity and Pulmonary Findings in Patients with Primary Immunodeficiency Using Scoring Systems
-
Evaluation of The Development of Respiratory Tract Allergic Disease in Patients With Cow’s Milk Allergy
-
Evaluation of The Development of Respiratory Tract Allergic Disease in Patients With Cow’s Milk Allergy
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Evaluation of the allergenicity of LTP proteins processed by proteolysis in an in vivo murine model
-
Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency
-
Ex-vivo fecal fermentation model demonstrates bifidogenic effect and beneficial metabolomic shift in response to two human milk oligosaccharides and lactose in infants with cow’s milk allergy
-
Exploring cardiovascular disease and mortality in Italian Common Variable Immunodeficiency (CVID) Patients: a multicenter investigation
-
Frequent occurrence of Alzheimer’s disease in patients with IgE-mediated allergies
-
Granulocytic myeloid derived suppressive cells exacerbate disease status in bronchiectasis
-
Hepatic Veno-Occlusive Disease with immunodeficiency Mutation in SP110
-
High burden of disease and risk of comorbidities in children with allergic rhinitis
-
Human milk oligosaccharides 3’SL and 6’SL suppress airway hyperreactivity, while only 3’SL also reduces airway inflammation in a murine allergic asthma model
-
Hymenoptera venom allergy as an occupational disease
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
Immune mechanisms associated with host-microbiome interactions in health and disease
-
Immunodeficiency in a Patient Undergoing Thymectomy for Congenital Heart Disease
-
Immunological Patient Stratification identifies distinct disease mechanisms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis
-
Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates allergic response in a murine model of allergic rhinitis
-
Involvement of activation of mast cells via IgE signaling and epithelial cell-derived cytokines in the pathogenesis of pollen-food allergy syndrome in a novel murine model
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Limiting unnecessary antibiotic use in allergic disease exacerbations
-
Linguistic Adaptation of Urticaria Activity Score Over 7 Days (UAS7) to Latvian: Evaluating Disease Activity in Adult Patients with Chronic Spontaneous Urticaria in Latvia
-
Long-term effects of COVID-19 on the risk of ischemic heart disease in asthma: A nationwide, population-based cohort study
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model
-
Minimal Invasive Endotyping in Nasal Inflammatory Disease
-
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
-
Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms
-
Multiomic approaches to study Inborn Errors of Immunity: RAG deficiency as a model
-
Novel Prediction Model of Early Screening Lung Adenocarcinoma with Pulmonary Fibrosis based on Haematological Index
-
Obesity in asthma: a treatable trait approach model of care
-
Optimising support for patients with asthma – a primary care model
-
Organ RNA profiles exploration in an active anaphylactic mice model with repeated challenges
-
Peripheral blood and urine lipid mediators are associated with NSAID-exacerbated respiratory disease
-
Pharmacogenetics of adverse effects induced by thiopurine drugs in patients with Inflammatory bowel disease
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Practical applications of ‘omics’ in chronic airway disease
-
Predictive model for postoperative unrecovered olfactory function in chronic rhinosinusitis patients with olfactory disorder
-
Primary antibody immune deficiencies are often associated with manifestations of allergic disease
-
Primary immunodeficiency in light of Granulomatous Lung Disease
-
Prognostic role of inflammaging markers on major adverse cardiac outcomes in atherosclerotic coronary artery disease
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
RHINA – Biomarkers in inflammatory airway disease
-
RHINA – Disease Mechanisms of CRS: from bench to bedside
-
Rapid clinical and immunological improvement of persistent lymphoproliferative disease in a patient with Activated PI3K Delta Syndrome (APDS)
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Results related to the implementation of a transdisciplinary care model in patients diagnosed with hereditary angioedema
-
Severe atopic dermatitis: a stand-alone disease or something more?
-
Shifting environmental exposures: a call for evolving allergic disease management
-
Slow crippling lung disease in Ataxia telangiectasia: lung function and CT findings
-
T2 driven disease therapy: How much is too much?
-
The Eosinophil in Obstructive Airway Disease – Beyond Asthma
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The Prevalence of NSAID‐exacerbated Respiratory Disease in one allergy center from China: Diagnosis adhering to EAACI Position Paper
-
The immune supportive diet for all patients with allergic disease – is a change is nutritional practice needed?
-
The potential role of IgE in Crohn’s disease by impairing the generation of FOXP3+ regulatory T cells by plasmacytoid dendritic cells
-
The potential role of IgE in Crohn’s disease by impairing the generation of FOXP3+ regulatory T cells by plasmacytoid dendritic cells
-
The role of the epithelium as a critical immune-functioning organ in both upper and lower airway disease
-
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Unique effect of aspirin on sputum cell composition in patients with NSAID-Exacerbated Respiratory Disease (N-ERD)
-
Unveiling the Connection Between α-Gal Allergy and Cardiovascular Disease
-
Upper respiratory disease and epithelial cytokines as potential therapeutic targets
-
Vitamin D3 deficiency disturbed immune response and respiratory function in the murine model of hypersensitivity pneumonitis
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS
Show more Sessions (124)Show Less-